The bacterium Salmonella causes a spectrum of foodborne diseases ranging from acute gastroenteritis to systemic infections, and represents a significant burden of disease globally. In Australia, Salmonella is frequently associated with outbreaks and is a leading cause of foodborne illness, which results in a significant medical and economic burden. A greater understanding of how Salmonella manipulates host cells during infection will lead to improved strategies to prevent, control, and eliminate disease. Further, studying effector proteins can be a useful means for exploring host cell biology and elucidating the details of host cell signalling.
Salmonella infections in Australia
Australia experiences an unusually high number of reported Salmonella infections, comprising a significant baseline of individually acquired infections, combined with a string of wellpublicised foodborne outbreaks Salmonella Anatum in bagged salads 4 , Salmonella Saintpaul on beansprouts 5 , and Salmonella Hvittingfoss on rockmelons 6 .
These outbreaks translate to a significant economic impact to the affected industries, in addition to the medical burden caused to the affected individuals 7, 8 .
Australia enjoys a high standard of public health surveillance, and
Salmonella infections are notifiable and publicly reported through the National Notifiable Diseases Surveillance System. These reports indicate more than 17 000 cases of Salmonella infection were reported in 2016 9 , and already more than 10 000 reported cases in 2017 at the time of writing 10 . These numbers are derived from a symptomatic person presenting to a healthcare professional, and so the true number of infections is likely to be significantly higher 11 . Salmonella therefore represents a significant public health concern.
Salmonella causes a range of disease states Ultimately, the diversity of Salmonella serovars and spectrum of diseases that it causes demonstrate a bacterium that is adept at persisting through the food supply chain, from contamination of farms and factories to restaurants and household kitchens, despite stringent food safety standards and public health surveillance.
Salmonella subverts host cells to achieve infection .
Salmonella employs two distinct type-three secretion systems at different stages of infection. These secretion systems translocate distinct cohorts of effector proteins into the host cell to achieve different goals for the bacterium. At early stages of infection, Salmonella uses the SPI-1 secretion system (encoded on the genomic region termed Salmonella pathogenicity island 1) to achieve uptake into non-phagocytic epithelial cells. Effector proteins translocated by this secretion system manipulate the host actin cytoskeleton to induce membrane ruffling, which enables bacterial uptake 21 . Shortly after invasion, the SPI-1 secretion system is downregulated and the bacterium is taken up into a phagocytic vacuole. Sensing the acidification of the vacuole, Salmonella then deploys the SPI-2 secretion system, which delivers another set of effectors into the host cytoplasm. Broadly, these effectors are responsible for remodelling the vacuole into a replication-permissive space (Figure 3 ), translocating and extending the vacuole along host microtubules, and interfering with the secretion of inflammatory cytokines 22, 23 . Together, these activities enable Salmonella to survive within both epithelia and phagocytic cells, to replicate to high numbers, and to disseminate to adjacent cells and on to new hosts. In Focus
Discovering the function of Salmonella effector proteins
It is well established that Salmonella relies on effector protein translocation to achieve infection -mutant strains lacking typethree secretion systems do not invade epithelia effectively, and are deficient in intracellular persistence host cell. Given that type-three secretion mutants are significantly attenuated during infection, it stands to reason that interfering with effector translocation represents a viable opportunity for developing novel anti-infective therapeutics. As we move towards a more complete understanding of the Salmonella-host interaction, it is likely that new opportunities will arise to antagonise the intracellular lifestyle of the bacteria. Ultimately, effective control and prevention of Salmonella infection will require a combination of human and animal vaccination, public health surveillance and food safety compliance, and effective therapeutic options.
